Professor Robert Steele,
Professor of Surgery & Head of Cancer Research
Publications List
Anderson, AS; Craigie, AM; Caswell, S; Treweek, S; Stead, M; Macleod, M; Daly, F; Belch, J; Rodger, J;
Kirk, A; Ludbrook, A; Rauchhaus, P; Norwood, P ; Thompson, J; Wardle, J;Steele, RJC; The impact of a
bodyweight and physical activity intervention (BeWEL) initiated through a national colorectal cancer
screening programme: randomised controlled trial; BMJ – British Medical Journal; 2014 March 7;
348; g1823.
Woods YL, Mukhtar S, McClements P, Lang J, Steele RJ, Carey FA. A survey of reporting of colorectal
cancer in Scotland: compliance with guidelines and effect of proforma reporting. J Clin Pathol. 2014
Feb 24. doi: 10.1136/jclinpath-2013-202060. [Epub ahead of print]
Steele, RJC; McClements, PL; Libby, G; Carey, FA; Fraser, CG; Patterns of uptake in a biennial faecal
occult blood test screening programme for colorectal cancer; Colorectal Disease; 2014 January; 16(1)
28-32.
Treweek, S; Wilkie, E; Craigie, AM; Caswell, S; Thompson, J; Steele, RJC; Stead, M; Anderson,
AS;Group Author(s): BeWEL Team; Meeting the challenges of recruitment to multicentre,
community-based, lifestyle-change trials: a case study of the BeWEL trial; Trials; 2013 December; 14;
436.
Morgan, RM; Steele, RJC; Nabi, G; McCowan, C; Socioeconomic Variation and Prostate Specific
Antigen Testing in the Community: A United Kingdom Based Population Study; Journal of Urology;
2013 October; 190(4) 1207-1212.
O'Carroll, RE; Steele, RJC; Libby, G; Brownlee, L; Chambers, JA; Anticipated regret to increase uptake
of colorectal cancer screening in Scotland (ARTICS): study protocol for a randomised controlled trial;
BMC Public Health; 2013 September; 13; 849.
Anderson, AS; Caswell, S; Wells, M; Steele, RJC; Obesity and lifestyle advice in colorectal cancer
survivors - how well are clinicians prepared?; Colorectal Disease; 2013 August; 15(8) 949-957
Young, JA; Waugh, L; McPhillips, G; Steele, RJC; Thompson, AM; Use of the high dependency unit,
increased consultant involvement and reduction in adverse events in patients who die after
colorectal cancer surgery; Colorectal Disease; 2013 July; 15(7) 824-829.
Digby, J; Fraser, CG; Carey, FA; McDonald, PJ; Strachan, JA; Diament, RH; Balsitis, M; Steele,
RJC;Faecal haemoglobin concentration is related to severity of colorectal neoplasia; Journal of
Clinical Pathology; 2013 May; 66(5) 415-419
Johnston, TJ; Tang, B; Alijani, A; Tait, I; Steele, RJ; Ker, J; Nabi, G. Laparoscopic Surgical Skills are
Significantly Improved by the Use of a Portable Laparoscopic Simulator: Results of a Randomized
Controlled Trial World Journal of Surgery; 2013 May; 37(5) 957-964.
Anderson, AS; Mackison, D; Boath, C; Promoting Changes in Diet and Physical Activity in Breast and
Colorectal Cancer Screening Settings: An Unexplored Opportunity for Endorsing Healthy Behaviors;
Cancer Prevention Research; 2013 March; 6(3) 165-172.
von Karsa, L ; Patnick, J; Segnan, N; Atkin, W; Halloran, S; Lansdorp-Vogelaar, I; Malila, N; Minozzi, S;
Moss, S; Quirke, P; Steele, RJ; European guidelines for quality assurance in colorectal cancer
screening and diagnosis: Overview and introduction to the full Supplement publication; Endoscopy;
2013 January; 45(1) 51-59.
Brewster DH, Clark DI, Stockton DL, Munro AJ, Steele RJC. Characteristics of patients dying within 30
days of diagnosis of breast or colorectal cancer in Scotland, 2003-2007. Br J Cancer 2011; 104: 60-67
Libby G, Bray, J, Champion J, Colford L, Birrell J, Gorman D, Crighton E, Fraser C, Steele RJC. Prenotification increases uptake of colorectal cancer screening in all demographic groups: a randomised
controlled trial. J Med Screening 2011; 18: 24-29
Steele RJC, McClements P, Watling C, Libby G, Weller D, Brewster DH, Black R, Carey FA, Fraser CG.
Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for
stage, gender and tumour site. Gut doi: 10.1136/gutjnl-2011-300535
Carrera A, McClements PL, Watling C, Libby G, Weller D, Brewster DH, Carey FA, Fraser CG, Steele
RJC. Negative screening colonoscopy after a positive guaiac faecal occult blood test: not a
contraindication to continued screening invitations. Colorectal Disease (in press)
Steele RJC, Brewster D. Should we judge cancer screening programmes by their effect on total
mortality rather on cancer specific mortality? BMJ 2011; 343: 938-939 (d6397)
Fraser CG, Digby J, McDonald PJ, Strachan JA, Carey FA, Steele RJC. Experience with a two-tier reflex
gFOBT/FIT strategy in a national bowel screening programme. J Med Screening (in press)
McDonald PJ, Strachan JA, Digby J, Steele RJC, Fraser CG. Faecal haemoglobin concentrations by
gender and age: implications for population-based screening for colorectal cancer. Clin Chem Lab
Med (in press)
Steele RJC, Kostourou I, McClements P, Watling C, Libby G, Weller D, Brewster D, Black R, Carey FA,
Fraser C. Effect of gender, age and deprivation on key performance indicators in a FOBT based
colorectal screening programme. J Med Screening 2010; 17: 68-74
Stephens RJ, Thompson LC, Quirke P, Steele RJC, Grieve R, Couture J, Griffiths GO, Sebag-Montefiore
D. The impact of short course pre-operative radiotherapy for rectal cancer on patients’ quality of
life: data from the Medical Research Council CR07/National Cancer Institute of Canada CTG CO16
randomised clinical trial. J Clin Oncol 2010; 27: 4233-4239
Fraser CG, McDonald PJ, Colford L, Irvine A, Kenicer M, Morton C, Birrell J, Steele RJC. Experience
with a wipe guaiac-based FOBT as an alternative test in a bowel screening programme. J Med
Screening 2010; 17: 211-213
Steele RJC, Kostourou I, McClements P, Watling C, Libby G, Weller D, Brewster DH, Black R, Carey FA,
Fraser C. Effect of repeated invitations on uptake of colorectal cancer screening using faecal occult
blood testing: analysis of prevalence and incidence screening. BMJ 2010; 341:
c5531doi:10.1136/bmj.c5531. Abridged print version : Br Med J 2010; 341: 977
Steele RJC. McClements PL, Libby G, Black R, Morton C, Birrell J, Mowat NAG, Wilson JA, Kenicer M,
Carey FA, Fraser CG. Results from the first three rounds of the Scottish Demonstration Pilot of FOBT
Screening for Colorectal Cancer. Gut 2009; 58: 530-535
Thaha MA, Campbell KL, Kazmi SA, Irvine LA, Khalil A, Binnie NR, Hendry WS, Walker A, Staines HJ,
Steele RJC. Prospective randomised multi-centre trial comparing clinical efficacy, safety and patient
acceptability of circular stapled anopexy with closed diathermy haemorrhoidectomy. Gut 2009; 58:
668-678
Sebag-Montefiore D, Stephens RJ, Steele RJC, Monson J, Grieve B, Khanna S, Quirke P, Couture J, de
Metz C, Myint S, Bessell E, Griffiths G, Thompson LC, Parmar M – on behalf of the trial collaborators.
Pre-operative radiotherapy versus selective post-operative radiotherapy in patients with rectal
cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009; 373: 811-820
Quirke P, Steele RJC, Monson J, Grieve R, Khanna S, Couture J, O’Callaghan C, Myint S, Bessell E,
Thompson LC, Parmar M, Stephens RJ, Sebag-Montefiore D, on behalf of the MRC CR07/NCIC-CTG
C016 trial investigators group and the NRCI colorectal cancer study group. Effect of the plane of
surgery achieved in patients with operable rectal cancer: a prospective study using data from the
MRC CR07 and NCIC-CTG C016 randomised trial. Lancet 2009; 373: 821-828
Rodger J, Steele RJC. Telephone assessment increases uptake of colonoscopy in a FOBT colorectal
cancer screening programme. J Med Screening 2008; 15: 105-107
Fraser CG, Matthew CM, McKay K, Carey FA, Steele RJC. Automated immunochemical quantitation
of haemoglobin in faeces collected on cards for screening for colorectal cancer. Gut 2008; 57: 12561260
Fraser CG, Matthew CM, Mowat NAG, Wilson JA, Carey FA, Steele RJC. Evaluation of a card
collection based faecal immunochemical test in screening for colorectal cancer using a two-tier
reflex approach. Gut 2007; 56: 1415-1418
Fraser CG, Matthew CM, Mowat NAG, Wilson J, Carey FA, Steele RJC. Immunological testing of
guaiac faecal occult blood test positive individuals in a colorectal cancer screening programme
facilitates clinical risk stratification. Lancet Oncology 2006; 7: 1-6
Conlin A, Smith g, Carey FA, Wolf CR, Steele RJC. The prognostic significance of K-ras, p53 and APC
mutations in colorectal carcinoma. Gut 2005; 54: 1283-1286
Steele RJC for the UK Colorectal Cancer Screening Pilot Group. Results of a demonstration pilot for
colorectal cancer screening in the United Kingdom. Br Med J 2004; 329: 133-135
Leslie A, Pratt NR, Gillespie K, Sales M, Kernohan NM, Smith G, Wolf R, Carey FA, Steele RJC.
Mutations of APC, K-ras and p53 are associated with specific chromosomal aberrations in colorectal
adenocarcinomas. Cancer Res 2003; 63: 4636-4661
Smith G, Carey FA, Beattie J, Wilkie MJV, Lightfoot TJ, Coxhead J, Garner RC, Steele RJC, Wolf CR.
Mutations in APC, Kirsten-ras, and p53 – alternative genetic pathways to colorectal cancer. Proc
Natl Acad Sci 2002; 99: 9433-9438
Leslie A, Carey FA, Pratt NR, Steele RJC. The colorectal adenoma-carcinoma sequence. Br J Surg
2002; 89: 845-860